Alerts will be sent to your verified email
Verify Email
VANTABIO
|
Vanta Bioscience
|
MIG Media Neurons
|
Varanium Cloud
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-9.14 % | n/a | 19.8 % |
|
5yr average Equity Multiplier
|
3.77 | n/a | 2.66 |
|
5yr Average Asset Turnover Ratio
|
0.14 | n/a | 0.85 |
|
5yr Avg Net Profit Margin
|
-22.86 % | n/a | 20.95 % |
|
Price to Book
|
0.0 | n/a | 0.0 |
|
P/E
|
0.0 | n/a | 0.22 |
|
5yr Avg Cash Conversion Cycle
|
-2109.35 Days | n/a | -1277.04 Days |
|
Inventory Days
|
349.3 Days | n/a | 0.0 |
|
Days Receivable
|
95.72 Days | n/a | 50.83 Days |
|
Days Payable
|
977.74 Days | n/a | 331.97 Days |
|
5yr Average Interest Coverage Ratio
|
0.56 | n/a | 687.1 |
|
5yr Avg ROCE
|
1.17 % | n/a | 50.69 % |
|
5yr Avg Operating Profit Margin
|
16.63 % | n/a | 39.73 % |
|
5 yr average Debt to Equity
|
2.28 | n/a | 0.71 |
|
5yr CAGR Net Profit
|
n/a | n/a | n/a |
|
5yr Average Return on Assets
|
-1.51 % | n/a | 16.17 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.36 % | n/a | 36.38 % |
|
Share Pledged by Promoters
|
0.0 | n/a | 43.5 % |
|
Change in Promoter Holding (3 Yrs)
|
-0.57 % | n/a | -26.84 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
Vanta Bioscience
|
MIG Media Neurons
|
Varanium Cloud
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|